A new review examines how advances in drug design, PROTAC degraders and combination therapies are reviving the clinical ...

Ovarian cancer has long proved difficult to treat. Could the answer lie within the disease itself? Discover how synthetic ...

A new review examines how advances in drug design, PROTAC degraders and combination therapies are reviving the clinical ...

Sanjeev Luther is President and CEO of Ernexa Therapeutics and a member of the Board of Directors. Sanjeev is a seasoned ...

Stanford University researchers have demonstrated that stem cell-derived vascular organoids can regenerate damaged ...

Preclinical findings from Genespire and SR-TIGET suggest a single administration of a liver-directed lentiviral gene therapy ...

A repurposed small molecule originally developed for spinal cord injury has demonstrated the ability to address multiple ...

A newly identified experimental compound, XL20, has demonstrated neuroprotective effects in mouse models and human motor ...

Researchers have identified 15-PGDH enzyme inhibition as a neuroprotective strategy in Parkinson's disease, with repurposable ...

Researchers at UMass Amherst have combined high-throughput laboratory screening with an AI neural network to identify ...

A collaborative research team from LJI, Scripps Research and IAVI has developed an experimental HIV vaccine that successfully ...

Scientists at MD Anderson Cancer Center have revealed how ATRX mutations restructure chromatin and activate oncogenic ...